Recent Anti-KRASG12D Therapies: A "Possible Impossibility" for Pancreatic Ductal Adenocarcinoma


Journal article


Navid Sobhani, Matteo Pittacolo, Alberto D'Angelo, Giovanni Marchegiani
Cancers, vol. 17(4), 2025


Cite

Cite

APA   Click to copy
Sobhani, N., Pittacolo, M., D'Angelo, A., & Marchegiani, G. (2025). Recent Anti-KRASG12D Therapies: A "Possible Impossibility" for Pancreatic Ductal Adenocarcinoma. Cancers, 17(4). https://doi.org/10.3390/cancers17040704


Chicago/Turabian   Click to copy
Sobhani, Navid, Matteo Pittacolo, Alberto D'Angelo, and Giovanni Marchegiani. “Recent Anti-KRASG12D Therapies: A &Quot;Possible Impossibility&Quot; for Pancreatic Ductal Adenocarcinoma.” Cancers 17, no. 4 (2025).


MLA   Click to copy
Sobhani, Navid, et al. “Recent Anti-KRASG12D Therapies: A &Quot;Possible Impossibility&Quot; for Pancreatic Ductal Adenocarcinoma.” Cancers, vol. 17, no. 4, 2025, doi:10.3390/cancers17040704.


BibTeX   Click to copy

@article{navid2025a,
  title = {Recent Anti-KRASG12D Therapies: A "Possible Impossibility" for Pancreatic Ductal Adenocarcinoma},
  year = {2025},
  issue = {4},
  journal = {Cancers},
  volume = {17},
  doi = {10.3390/cancers17040704},
  author = {Sobhani, Navid and Pittacolo, Matteo and D'Angelo, Alberto and Marchegiani, Giovanni}
}